This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of California. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Jack F Youngren: Innovator in Cancer Treatment
Introduction
Jack F Youngren is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of cancer treatment, particularly through his innovative research on tyrosine kinase receptor antagonists.
Latest Patents
Youngren holds a patent for "Tyrosine kinase receptor antagonists and methods of treatment for breast cancer." This patent describes a method of treatment where cancer cells are brought into contact with a formulation that includes an inhibitor of tyrosine kinase receptors. The formulation may consist of an injectable carrier and two or more tyrosine kinase receptor inhibitors, which can include nordihydroguaiarectic acid (NDGA) and doxorubicin. He has 1 patent to his name.
Career Highlights
Youngren is affiliated with the University of California, where he continues to advance his research in cancer therapies. His work has the potential to impact the treatment landscape for breast cancer significantly.
Collaborations
Some of his notable coworkers include Ira D Goldfine and John Kerner, who have collaborated with him on various research initiatives.
Conclusion
Jack F Youngren's innovative work in cancer treatment exemplifies the vital role of inventors in advancing medical science. His contributions are paving the way for new therapeutic approaches in the fight against breast cancer.